Company Valuation: West Pharmaceutical Services, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 34,744 17,424 26,053 23,723 19,795 24,591 - -
Change - -49.85% 49.53% -8.95% -16.56% 24.23% - -
Enterprise Value (EV) 1 34,744 16,738 25,406 23,441 19,206 24,087 23,552 23,132
Change - -51.82% 51.78% -7.74% -18.07% 25.42% -2.22% -1.78%
P/E 54.1x 30.4x 44.7x 49x 40.5x 40.7x 35.4x 31.6x
PBR 14.9x 6.5x 8.98x 8.83x 5.95x 7.85x 6.85x 6.06x
PEG - -2.8x 23.04x -3.2x 27.09x 1.5x 2.4x 2.6x
Capitalization / Revenue 12.3x 6.04x 8.83x 8.2x 6.44x 7.29x 6.86x 6.38x
EV / Revenue 12.3x 5.8x 8.61x 8.1x 6.25x 7.14x 6.57x 6x
EV / EBITDA 39.3x 19x 30.7x 32.2x 24.2x 25.6x 22.6x 20x
EV / EBIT 45.6x 22x 36.8x 40.9x 30.9x 31.8x 27.8x 24.3x
EV / FCF 105x 38.1x 61.3x 84.8x 41x 55.9x 41.5x 31.9x
FCF Yield 0.95% 2.63% 1.63% 1.18% 2.44% 1.79% 2.41% 3.13%
Dividend per Share 2 0.69 0.74 0.78 0.82 0.85 0.9025 0.9729 1.121
Rate of return 0.15% 0.31% 0.22% 0.25% 0.31% 0.26% 0.28% 0.32%
EPS 2 8.67 7.73 7.88 6.69 6.79 8.575 9.865 11.04
Distribution rate 7.96% 9.57% 9.9% 12.3% 12.5% 10.5% 9.86% 10.2%
Net sales 1 2,832 2,887 2,950 2,893 3,074 3,375 3,587 3,854
EBITDA 1 884.7 882.6 827.9 728.2 793.8 940.4 1,041 1,159
EBIT 1 762.4 762 690.6 572.8 622.4 757.5 848.4 952.3
Net income 1 661.8 585.9 593.4 492.7 493.7 614.5 701.2 778
Net Debt 1 - -685.4 -647.1 -282 -588.5 -503.3 -1,039 -1,458
Reference price 2 469.01 235.35 352.12 327.56 275.14 349.42 349.42 349.42
Nbr of stocks (in thousands) 74,080 74,033 73,990 72,422 71,943 70,376 - -
Announcement Date 2/17/22 A 2/16/23 A 2/15/24 A 2/13/25 A 2/12/26 A - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
31.91x4.3x16.65x2.31% 193B
20.68x3.58x12.58x3.26% 117B
17.18x0.2x12.43x0.76% 59.89B
32.51x8.12x20.71x1.22% 56.01B
35.34x3.41x11.7x2.14% 49.96B
35.98x6.33x19.87x-.--% 33.87B
46.51x1.32x12.08x0.16% 31.36B
20.88x3.19x11.7x1.4% 24.77B
40.75x7.14x25.62x0.26% 24.59B
Average 31.30x 4.18x 15.93x 1.28% 65.53B
Weighted average by Cap. 29.45x 4.06x 15.49x 1.85%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. WST Stock
  4. WPS Stock
  5. Valuation West Pharmaceutical Services, Inc.